Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01128946 · ClinicalTrials.gov registry record · Phase 4

Enamel Remineralization Potential of Dentifrices in Situ

A Phase 4 study of Dental Caries, sponsored by GlaxoSmithKline.

Completed
Registry status
Phase 4
Development phase
83
Enrollment target
1
Study location

NCT01128946 is a Phase 4 study of Dental Caries that has completed, run by GlaxoSmithKline. The registered enrollment target is 83 participants, below the 719-participant average among 30 other Dental Caries trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01128946, a Phase 4 study of Dental Caries, has completed, sponsored by GlaxoSmithKline.

COMPLETED
Registry status
Phase 4
Development phase
83 participants
Enrollment target
1
Study location

Study Summary

This study will use an oral in-situ caries model to study remineralization of enamel due to the action of different combinations of fluoride salts delivered from dentifrices.

Conditions Studied

Interventions

  • DRUG NaF
  • DRUG SnF
  • DRUG NaMFP

Study Locations (1)

Indiana

  • Indiana University School of Dentistry - Indianapolis

Trial Details

FieldValue
Enrollment Target 83 participants
Start Date 2009-11
Est. Completion 2010-03
Phase Phase 4

Sponsor

GlaxoSmithKline

1,345 total trials

What the Registry Record Tells You About NCT01128946

The ClinicalTrials.gov registry entry for NCT01128946 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 719-participant average among 30 other Dental Caries trials with a reported enrollment target (88% lower). The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dental Caries appearing as the primary indexed condition, and to 3 interventions - of which NaF is the first listed.

NCT01128946 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT01128946 about?

NCT01128946 is a clinical study titled "Enamel Remineralization Potential of Dentifrices in Situ". This study will use an oral in-situ caries model to study remineralization of enamel due to the action of different combinations of fluoride salts delivered from dentifrices.

What is the current status of trial NCT01128946?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 83 participants. The study started on 2009-11. Estimated completion is 2010-03.

What conditions does trial NCT01128946 study?

This clinical trial studies the following conditions: Dental Caries.

What interventions are being tested in trial NCT01128946?

The interventions under investigation include: NaF (DRUG), SnF (DRUG), NaMFP (DRUG).

Who is sponsoring clinical trial NCT01128946?

This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01128946 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dental Caries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.